Heart risk persists despite intense management in diabetes study

09/14/2011 | InternalMedicineNews.com (free registration)

Intensive heart disease management does not reduce the risk of cardiovascular events compared with standard care in patients with screen-detected type 2 diabetes, according to a subanalysis of a randomized study of European patients. The conclusions were consistent with the main findings of ADDITION-Europe that early detection and treatment were more important than intensive treatment.

View Full Article in:

InternalMedicineNews.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC